It is the need of the hour to speed up the development of new compounds in the pharmaceutical industry. At the early stages of drug development, many compounds are screened as rapidly as possible to identify the optimal lead compounds. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is essential for high-throughput quantitative analysis of the compounds. Because LC-MS/MS is more sensitive and selective for biological samples than other methods, it is popular in various fields, including pharmacokinetics and toxicokinetics. High-throughput analysis with LC-MS/MS plays a key role in speeding up drug discovery.
the pressure in the column to be much lower than that in a conventional column of silica gel. Therefore, LC-MS/MS analysis can be carried out at a high flow rate using a monolithic column, speeding up the analysis. However, analysis of polar compounds such as metabolites and endogenous substances cannot be carried out using a monolithic column because the retention capability for these compounds is poorer than that of an octa decyl silyl (ODS) column and the lineup such as the bore diameter and length of monolithic column is not enough. Next, parallel LC-MS/MS method is also an option that could increase the throughput. [12] [13] [14] This method employs multiple HPLC systems and columns connected in parallel to an MS system, [15] [16] [17] [18] and the eluted analyte from each HPLC system is alternately introduced into the MS system through a switching valve. Hence, the time spent before and after the elution of analytes can be diverted to detect the analytes eluted from other systems, thus considerably speeding up the analysis. However, this method requires specialized equipment and involves preparation of individual calibration curves for each system, even for the same analyte.
In this study, we focused on maximizing the throughput of pharmacokinetic studies, and we developed a new method with conventional instruments, which lowers costs and effort. We named this approach multiple injection method (MIM), as multiple compounds are continuously injected one after another into a column and analyzed simultaneously by LC-MS/MS. The objective of this study was to establish the effectiveness of the method in accelerating pharmacokinetic studies.
MATERIALS AND METHODS

Chemicals and Reagents
Verapamil, risperidone, ondansetron, and paclitaxel were purchased from Wako (Osaka, Japan). Fexofenadine, imipramine, colchicine, and etoposide were obtained from Sigma-Aldrich (St. Louis, MO, U.S.A.). Water of HPLC grade was obtained from Nacalai Tesque (Kyoto, Japan). Dimethyl sulfoxide of special grade, formic acid of special grade, and acetonitrile and isopropanol of HPLC grade were purchased from Kanto Chemicals (Tokyo, Japan).
Methods MIM consists of two steps (Fig. 1 ).
Step 1 involves injection: compounds are continuously injected one after another into a column and trapped at the column head under an isocratic condition of low organic solvent proportion.
Step 2 involves elution: all compounds trapped at the column head are eluted together and introduced into the MS.
Instruments The HPLC system consisted of two LC10ADvp pumps, an SIL-HTC autoinjector, a CTO-10ACvp column oven, and a 10ADvp sample cooler (Shimadzu Corp., Kyoto, Japan). The UHPLC system (UPLC ® ) consisted of sample manager, binary solvent manager, and sample organizer (Waters Co., Milford, U.S.A.). MS detection was performed on a Quattro Ultima triple quadrupole mass spectrometer (Micromass Inc., Manchester, U.K.). The LC-MS/MS system was controlled by Masslynx TM 4.0 and the Quanlynx TM application manager.
HPLC Conditions
The HPLC conditions in steps 1 and 2, shown in Fig. 1 , are described below ( Table 1) . The mobile phase consisted of (A) 0.1% formic acid in water and (B) 0.1% formic acid in acetonitrile. Isopropanol was used as the wash solvent in the autosampler. Chromatography separation was carried out using an XBridge TM C18 column (2.1ϫ50 mm i.d., 5 mm) and Acquity UPLC BEH C18 column (2.1ϫ50 mm i.d., 1.7 mm) (Waters Co., Milford, U.S.A.). The column oven and sample cooler were kept at 40°C and 10°C, respectively, throughout the analysis.
MS Conditions
The MS system was operated in the multiple reaction monitoring (MRM) mode using positive ion electrospray ionization. The electrospray capillary voltage was set at 3.0 kV, and the temperatures of the source and desolvation were set at 150°C and 450°C, respectively. The desolvation gas flow was set at 700 l/h. The MRM transitions of compounds used in this study are listed below ( Table 2 ). The dwell time was 330 ms for each channel.
Preparation of Standards for Calibration Curves and Quality Control (QC) Analysis
The model compounds for MIM-fexofenadine, verapamil, risperidone, ondansetron, and imipramine ( Fig. 2) -were weighed and dissolved in dimethyl sulfoxide to prepare stock solutions (1 mg/ml). Each stock solution was diluted stepwise with acetonitrile to prepare the standard solutions for calibration curves at concentrations of 1.5, 5, 15, 50, 150, and 500 ng/ml. The calibration samples were prepared as follows. The standard solutions (20 ml), blank rat plasma (20 ml), and acetonitrile (480 ml) were transferred into a 96-well plate. They were then mixed using a plate shaker for a few minutes and centrifuged at 3000 rpm for 15 min at 10°C. The standard solutions for the QC samples were prepared at concen- Step 1: Injection step Step 2: Elution step trations of 150, 1500, and 20000 ng/ml. The QC samples (5, 50, 400 ng/ml) were obtained by spiking blank rat plasma with the QC standard solutions. Then 500 ml of acetonitrile were added to 20 ml of the QC samples into a 96-well plate, followed by mixing and centrifugation in the same manner as above. Sample Preparation Briefly, 500 ml of acetonitrile was added to 20 ml of the rat plasma samples into a 96-well plate. They were then mixed for a few minutes using the plate shaker and centrifuged at 3000 rpm for 15 min at 10°C. The supernatant (5 ml) was injected into the LC-MS/MS system.
Accuracy and Precision
The accuracy and precision for intra-day and inter-day analyses were evaluated by determining the five sets of QC samples on three different days. The accuracy should be within Ϯ15% at each concentration. The precision should not exceed 15% at each concentration.
Recovery and Matrix Effects The recovery was investigated using three concentrations (5, 50, 400 ng/ml). The recovery ratios were calculated using the following formula: [the peak area of an extracted sample]/[the peak area of a corresponding blank plasma sample to which a known amount of standard solutions was added after precipitation of plasma proteins].
The matrix effects were evaluated using a single concentration (50 ng/ml). The matrix effects were calculated using the following formula: [the peak area of an extracted blank plasma sample spiked with the standard solution]/[the peak area of the standard solution diluted in acetonitrile to the same concentration].
Comparison of MIM with the Pre-mix Method We compared the peak shapes and sensitivities obtained from the two methods because the pre-mix method involved mixing of the various samples and was considered as an alternative to speed up the analysis.
We investigated the injection volume for the plasma samples of each model compound at a concentration of 50 ng/ml in MIM. On the other hand, the pre-mix samples, where each supernatant was extracted from the plasma samples at a concentration of 50 ng/ml, were mixed with each other before they were analyzed at a concentration of 10 ng/ml.
Investigation of the Ionization Interaction
We investigated the effects of overlapping analytes on the responses of the model compounds in order to estimate the ionization interaction among the co-eluted analytes. The concentration of these plasma samples was 50 ng/ml. Colchicine, etoposide, and paclitaxel were also used as model compounds to investigate the difference in the sensitivity. Then, plasma samples with concentrations of 1.5, 15, 150, and 1500 ng/ml for the five model compounds were prepared to investigate the effects arising due to different concentrations.
Applications in Pharmacokinetic Studies Male Sprague-Dawley rats (weighting 300-350 g) were purchased from Charles River Japan (Yokohama, Japan) and used in this study. Under the fed condition, 10 mg/kg of fexofenadine and verapamil, 20 mg/kg of risperidone, 2 mg/kg of ondansetron, and 30 mg/kg of imipramine were orally administrated to rats by gavage (nϭ2/compound). [19] [20] [21] [22] [23] [24] [25] [26] The volume of a dose of the 0.5% methylcellulose suspension was 2 ml/kg for each model compound. Blood samples (200 ml) were collected at 0.25, 0.5, 1, 2, and 6 h after oral administration. The plasma was separated by centrifugation at 3000 rpm for 10 min at 10°C and stored at Ϫ45°C prior to analysis.
RESULTS AND DISCUSSION
Calibration Curve
The calibration curves of model compounds were fairly linear over the concentration range 1.5-500 ng/ml. The correlation coefficient values of the calibration curves for all the five model compounds were over 0.99. The mean, accuracy, and precision for the concentration back-calculated from each calibration curve in MIM are summarized in Table 3 . The accuracies ranged from 89.5 to 108.1%, and all the precisions were less than 10.1% in terms of the relative standard deviations (RSDs).
Accuracy and Precision The accuracy and precision for intra-day and inter-day analysis were determined by analyzing the five sets of QC samples on three different days. The accuracy and precision data can be seen in Table 4 . The intraday accuracies for all the model compounds ranged from 88.4 to 108.3%, and the precisions were less than 11.6% over the entire concentration range. The inter-day accuracy and precision were 89.6-107.1% and less than 6.5%, respectively. These range of values met the general criteria (accuracy Ϯ15%, precision Յ15%) for bioanalytical quantification as stipulated by Food and Drug Administration (FDA). [27] [28] [29] Recovery and Matrix Effects The values of recovery and the matrix effects were calculated using the formula described in the experimental section. Average recoveries of the recovery samples were 114Ϯ4.7% for fexofenadine, 107Ϯ 2.1% for verapamil, 115Ϯ4.7% for risperidone, 108Ϯ2.3% for ondansetron, and 98.8Ϯ3.1% for imipramine that indicated good recovery for all the model compounds. Therefore, we concluded that this sample preparation method can be used for quantitative measurement.
27)
The matrix effects values were 114Ϯ3.5% for fexofenadine, 109Ϯ2.2% for verapamil, 111Ϯ1.4% for risperidone, 114Ϯ3.8% for ondansetron, and 99.3Ϯ4.4% for imipramine, thus indicating that the analysis of all the model compounds was not interfered by the endogenous substances present in the plasma.
MIM vs. the Conventional Method
The results obtained from MIM were compared with those from the conventional method using the QC samples ( Table 5 ). The ratios of the average values of the measured concentrations for these two methods were close to 1, suggesting that MIM is almost as highly sensitive as the conventional method for all the model compounds.
The greatest advantage offered by MIM is faster analysis. We compared MIM with the conventional method to estimate the reduction analytical time (Fig. 3) . The conventional method required 150 min to analyze the calibration curve samples at six concentrations (30 min for each compound). However, MIM required only 42 min (8.4 min for each compound), which was approximately one third the time required by the conventional method. Therefore, it is suggested that MIM is a high-throughput quantitative method that is as precise as the conventional method. Additionally, the analytical time can be further reduced by MIM if the number of continuous injected compounds is increased any more.
Comparison of MIM with Pre-mix Method MIM is faster as it enables injection of multiple samples and simultaneous analysis by MS/MS; however, in terms of analytical time, the pre-mix method is slightly superior. In the case of the pre-mix method, the injection volume needs to be increased in order to introduce an equal amount of each compound into the MS because the concentration of each analyte is reduced when they are mixed. We tested the sensitivity and observed the chromatogram afforded by the pre-mix method As the injection volume for MIM was 5 ml for each compound, for the pre-mix sample, it was 25 ml. The chromatograms obtained from the two experiments are shown in Figs. 4a and b . The peak shapes of each compound in the pre-mix method are disrupted suggesting that compounds partially pass through the column because of the elution, not due to the mobile phase, but the injected solvents. Moreover, the pre-mix method, when compared to MIM, afforded lower sensitivity for each compound. MIM required only a small injection volume because the samples were not diluted. Thus, the pre-mix method is considered impractical due to its low sensitivity.
In order to compensate for the low sensitivity of the premix method, a bypass line that can dilute the injected sample with an aqueous mobile phase could be useful. 30) Unfortunately, this method requires some modifications and expert control over the inlet system that renders it unsuitable for high-throughput screening. Furthermore, although it is possible to inject a large volume of the sample in the organic solvent by column switching, this method is inefficient for highthroughput analysis because it requires some optimization, specialized trapped columns, and additional equipment. 31, 32) By contrast, MIM easily carries out the high-throughput analysis without any compound-dependent optimization or additional equipment.
Comparison of MIM with Cassette Dosing Cassette dosing is widely used in early stage of drug metabolism and pharmacokinetics. This method has advantages of reduction of both animal numbers and effective acquisition of pharmacokinetic parameters, however there are limits to administrated dose and the number of combined compounds (up to 5 compounds) due to the risk of drug-drug interaction. 33) On the other hand, MIM is the method to improve analytical throughput. Therefore, it is unnecessary to consider the risk of drug-drug interaction even if MIM is used for the measurement of compounds in biological samples at both efficacy and toxicity doses. In addition, much higher-throughput could be easily achieved because samples of cassette dosing could be also determined by MIM. For example, in the case of measuring the samples of three cassette dosing, each of which contains three compounds, by MIM, the analytical time was not only reduced 2.5 fold, but the accuracy of these samples was also excellent (data not shown). In the case of this study, we confirmed that up to 20 compounds could be continuously injected to the LC-MS/MS system by MIM because the maximum number of combined compounds is dependent on minimum dwell time of mass spectrometer (0.01 s in this study) without sacrificing the sensitivity and the accuracy (data not shown).
Application of MIM to the UHPLC System Recently, ultra high performance liquid chromatography (UHPLC) has become popular as an inlet device for high-throughput analysis using LC-MS/MS. 34, 35) The UHPLC system employs sub-2 mm particles which enable very high resolution even at a high flow rate, but small filler particles cause extremely high pressure. Therefore, this system requires special devices which are robust enough to withstand high back-pressure. We hypothesized that further reduction of analytical time could be achieved by the UHPLC system in MIM instead of the HPLC system. Using five model compounds, the analytical time was reduced by half of conventional method (data not shown). Although efficiency of the analytical time reduction was a little lower than expected from the results of the HPLC system, this is because the proportion of interval times between injections to total analytical time was higher than that of the HPLC system. However, we could confirm that MIM could be applied not only to the HPLC system but also to the UHPLC system.
Investigation of Ionization Interaction
In some cases of MIM, the analytes were co-eluted owing to the fast analysis. In fact, all the model compounds exhibited almost identical retention times under the HPLC conditions of this experiment (Fig. 4a) . Recently, no ion suppression was reported for co-eluted compounds. 36) Therefore, the ion suppression effect among co-eluted compounds was investigated by MIM.
Among the five model compounds, the least sensitivity was obtained for imipramine and the highest for verapamil. The difference in sensitivity is less than 10 times, which is insufficient to estimate the interaction caused by the difference in ionization efficiency. Therefore, additional compounds such as colchicine, etoposide, and paclitaxel having lower ionization efficiency than imipramine were also employed for this investigation. Consequently, we investigated the influence of co-elution of compounds with 100-fold difference in ionization efficiency. As a result, these additional compounds were co-eluted without any influence on the response of each model compound.
Secondly, we investigated the ionization interaction caused by the difference in the concentrations under the co-elution condition. The concentration of risperidone in the plasma sample was fixed at 1.5 ng/ml; and those of imipramine, verapamil, fexofenadine, and ondansetron were 10, 100, and 1000 times as high as that of risperidone. We conducted an investigation similar to the previously mentioned one to estimate the influence of these compounds on the response of verapamil. The results show that even if compounds at high concentration-up to 1000 times higher-are eluted together with risperidone or verapamil, no interaction is observed on the response of each compound. Therefore, these results suggest that compounds with various sensitivities and concentrations have no influence on the responses of the compounds provided the ionization interaction is maintained under the co-elution condition. But, in general, we have to call attention to the possibility that the ionization interaction might be changed for some compounds under the co-elution condition in MIM measurement.
Applications in Pharmacokinetic Studies
MIM was employed to analyze the five model compounds in rat plasma after oral administration. The plasma concentrations of the model compounds were determined by both MIM and the conventional method. Analyzing the calibration curve samples and QC samples in every run proved the analysis to be effective. The comparison of the mean values obtained from both methods is shown in Fig. 5 . The quantitative values obtained from both methods were almost equal, and the slopes of the correlation graphs of the model compounds for both methods ranged from 0.96 to 1.1. Therefore, MIM was confirmed to be a feasible alternative for quantitative analysis in pharmacokinetic studies.
CONCLUSION
A novel analytical method named multiple injection method (MIM) was developed for higher-throughput LC-MS/MS analysis. It substantially reduced the analytical time without compromising the accuracy or precision of the quantitative analysis. We used five model compounds to validate the feasibility of MIM in this study; however, the analytical time per compound can be further reduced if more than five compounds are analyzed by MIM. In the meanwhile, we were able to optimize the HPLC method to enhance its sepa-ration performance-at the cost of a longer analytical timeif the analytes exhibit poor separation. Therefore, we concluded that the HPLC method needs to be carefully selected on the basis of an optimum blend of separation performance and speed. MIM shows promise as a very helpful and powerful method for the measurement of unchanged form of compounds in biological samples in pharmacokinetic studies and in accelerating drug development at the discovery stages. Plasma samples 2 and 6 h after oral administration of ondansetron were below lower limit of quantification (Ͻ1.5 ng/ml).
